Figure 3.

REDUCE-IT trial prespecified endpoints. The rates of all endpoints, except death from any cause, were significantly lower in icosapent ethyl (eicosapentaenoic acid ethyl esters). Data were adapted from NEJM [5] and reproduced with Mayo Clinic Proc [57] permission.